recombinant anti-IL-1β humanized monoclonal antibody

anti-IL-1β monoclonal antibody · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for recombinant anti-IL-1β humanized monoclonal antibody, covering 2022-10-20 to 2023-12-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout [Phase 3]

See pricing